201 related articles for article (PubMed ID: 16616827)
21. Pemetrexed for diffuse malignant pleural mesothelioma.
Manegold C; Aisner J
Semin Oncol; 2002 Apr; 29(2 Suppl 5):30-5. PubMed ID: 12023790
[TBL] [Abstract][Full Text] [Related]
22. Malignant peritoneal mesothelioma (MPM) who responded to rechallenge with cisplatin and pemetrexed with current literature review.
Gilani SN; Gridley R; Searle G; Jegannathen A
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23291819
[TBL] [Abstract][Full Text] [Related]
23. Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma.
Ceresoli GL; Zucali PA
Cancer Treat Rev; 2015 Dec; 41(10):853-8. PubMed ID: 26526504
[TBL] [Abstract][Full Text] [Related]
24. [Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis].
Tanaka A; Takahashi T
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):383-7. PubMed ID: 19514499
[TBL] [Abstract][Full Text] [Related]
25. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Taylor L; Ashland J; Ye Z; Monberg MJ; Obasaju CK
Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
Reck M; Heigener DF; Gatzemeier U
Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
[TBL] [Abstract][Full Text] [Related]
27. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
Simon GR; Verschraegen CF; Jänne PA; Langer CJ; Dowlati A; Gadgeel SM; Kelly K; Kalemkerian GP; Traynor AM; Peng G; Gill J; Obasaju CK; Kindler HL
J Clin Oncol; 2008 Jul; 26(21):3567-72. PubMed ID: 18640937
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
Habib EE; Fahmy ES
Clin Transl Oncol; 2013 Nov; 15(11):965-8. PubMed ID: 23408040
[TBL] [Abstract][Full Text] [Related]
29. [A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy].
Igarashi K; Hayashi M; Sato M; Aiba T; Yoneyama O; Waguri N; Furukawa K; Sugimura K; Shibuya H
Nihon Shokakibyo Gakkai Zasshi; 2012 Mar; 109(3):451-9. PubMed ID: 22398911
[TBL] [Abstract][Full Text] [Related]
30. Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases.
Nakano M; Kusaba H; Makiyama A; Ariyama H; Arita S; Oda H; Esaki T; Takayoshi K; Uchino K; Tamura S; Kumagai H; Iwama E; Shirakawa T; Mitsugi K; Takaishi S; Akashi K; Baba E
Anticancer Res; 2014 Jan; 34(1):215-20. PubMed ID: 24403465
[TBL] [Abstract][Full Text] [Related]
31. Pemetrexed-cisplatin combination in mesothelioma.
Reck M; Gatzemeier U
Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
[TBL] [Abstract][Full Text] [Related]
32. Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.
Suwanrusme H; Meyer ML; Green MR
Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S56-60. PubMed ID: 15117426
[TBL] [Abstract][Full Text] [Related]
33. [A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin].
Kobayashi M; Moriwaki T; Ochi D; Saito R; Kobayashi K; Sugaya A; Akutsu D; Hamano Y; Imanishi M; Yamamoto Y; Yamada T; Nakano N; Sugano M; Hara K; Hyodo I
Gan To Kagaku Ryoho; 2014 Mar; 41(3):361-4. PubMed ID: 24743284
[TBL] [Abstract][Full Text] [Related]
34. Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study.
Mutlu H; Gündüz S; Karaca H; Büyükçelik A; Cihan YB; Erden A; Akca Z; Coşkun HS
Med Oncol; 2014 Aug; 31(8):74. PubMed ID: 24958517
[TBL] [Abstract][Full Text] [Related]
35. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
Opitz I; Kestenholz P; Lardinois D; Müller M; Rousson V; Schneiter D; Stahel R; Weder W
Eur J Cardiothorac Surg; 2006 Apr; 29(4):579-84. PubMed ID: 16495068
[TBL] [Abstract][Full Text] [Related]
36. Current chemotherapeutic treatment of malignant pleural mesothelioma.
Nowak AK; Byrne MJ; Millward MJ; Alvarez JM; Robinson BW
Expert Opin Pharmacother; 2004 Dec; 5(12):2441-9. PubMed ID: 15571462
[TBL] [Abstract][Full Text] [Related]
37. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials.
Treat J; Scagliotti GV; Peng G; Monberg MJ; Obasaju CK; Socinski MA
Lung Cancer; 2012 May; 76(2):222-7. PubMed ID: 22115704
[TBL] [Abstract][Full Text] [Related]
39. Standard therapy for the treatment of malignant pleural mesothelioma.
Vogelzang NJ
Lung Cancer; 2005 Oct; 50 Suppl 1():S23-4. PubMed ID: 16291429
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.
Kitadai R; Shimoi T; Sudo K; Noguchi E; Nagata Y; Sawada R; Takashima A; Boku N; Yonemori K
BMC Cancer; 2021 Mar; 21(1):294. PubMed ID: 33743636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]